RELISTOR
Google image searchProduct monograph
Active ingredient
methylnaltrexone bromide, 20 MG/ML
DIN: 02308215
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: 12MG/0.6ML - SINGLE USE VIAL.
Schedule: Prescription
Company: SALIX PHARMACEUTICALS INC
Date: 18-JAN-2021
ATC:
- A06 — LAXATIVES (ATC, ATC/DDD, )
- A06A — LAXATIVES (ATC, ATC/DDD)
- A06AH — Peripheral opioid receptor antagonists (ATC, ATC/DDD)
- A06AH01 — METHYLNALTREXONE BROMIDE (ATC/DDD)
Reference brand drug: Relistor
